GO:0005634 | nucleus | 3.12e-06 | 4.50e-02 | 1.662 | 11 | 159 | 4559 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 2.08e-05 | 3.00e-01 | 5.732 | 3 | 4 | 74 |
GO:0044822 | poly(A) RNA binding | 5.09e-05 | 7.35e-01 | 2.897 | 6 | 50 | 1056 |
GO:0005654 | nucleoplasm | 5.85e-05 | 8.43e-01 | 2.862 | 6 | 64 | 1082 |
GO:0044212 | transcription regulatory region DNA binding | 2.39e-04 | 1.00e+00 | 4.549 | 3 | 17 | 168 |
GO:0016607 | nuclear speck | 2.56e-04 | 1.00e+00 | 4.515 | 3 | 12 | 172 |
GO:0008380 | RNA splicing | 5.86e-04 | 1.00e+00 | 4.109 | 3 | 22 | 228 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:1901673 | regulation of spindle assembly involved in mitosis | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0043578 | nuclear matrix organization | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0010965 | regulation of mitotic sister chromatid separation | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0006404 | RNA import into nucleus | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0031453 | positive regulation of heterochromatin assembly | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0005643 | nuclear pore | 8.25e-04 | 1.00e+00 | 5.524 | 2 | 11 | 57 |
GO:0000189 | MAPK import into nucleus | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0031990 | mRNA export from nucleus in response to heat stress | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 2 | 2 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0090204 | protein localization to nuclear pore | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0070840 | dynein complex binding | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0002944 | cyclin K-CDK12 complex | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0046832 | negative regulation of RNA export from nucleus | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0006405 | RNA export from nucleus | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 2 | 3 |
GO:0042306 | regulation of protein import into nucleus | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 2 | 3 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0001650 | fibrillar center | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0051726 | regulation of cell cycle | 2.37e-03 | 1.00e+00 | 4.757 | 2 | 5 | 97 |
GO:0014044 | Schwann cell development | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0030578 | PML body organization | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0006999 | nuclear pore organization | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0044615 | nuclear pore nuclear basket | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.38e-03 | 1.00e+00 | 3.231 | 3 | 30 | 419 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0010793 | regulation of mRNA export from nucleus | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0043405 | regulation of MAP kinase activity | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070849 | response to epidermal growth factor | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0050733 | RS domain binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0005730 | nucleolus | 4.85e-03 | 1.00e+00 | 1.998 | 5 | 66 | 1641 |
GO:0046825 | regulation of protein export from nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 2 | 7 |
GO:0051292 | nuclear pore complex assembly | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 8 |
GO:0035457 | cellular response to interferon-alpha | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0006397 | mRNA processing | 6.30e-03 | 1.00e+00 | 4.035 | 2 | 10 | 160 |
GO:0042405 | nuclear inclusion body | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 2 | 9 |
GO:0043495 | protein anchor | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0031965 | nuclear membrane | 6.92e-03 | 1.00e+00 | 3.964 | 2 | 10 | 168 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 10 |
GO:0031625 | ubiquitin protein ligase binding | 7.74e-03 | 1.00e+00 | 3.881 | 2 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.25e-03 | 1.00e+00 | 3.833 | 2 | 22 | 184 |
GO:0005515 | protein binding | 8.30e-03 | 1.00e+00 | 0.970 | 9 | 198 | 6024 |
GO:0019789 | SUMO ligase activity | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0045947 | negative regulation of translational initiation | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 2 | 12 |
GO:0034399 | nuclear periphery | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 5 | 12 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0005868 | cytoplasmic dynein complex | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0046827 | positive regulation of protein export from nucleus | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0003677 | DNA binding | 1.03e-02 | 1.00e+00 | 2.106 | 4 | 49 | 1218 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 6 | 14 |
GO:0005487 | nucleocytoplasmic transporter activity | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 3 | 14 |
GO:0042809 | vitamin D receptor binding | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 6 | 15 |
GO:0042307 | positive regulation of protein import into nucleus | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 4 | 15 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0019221 | cytokine-mediated signaling pathway | 1.17e-02 | 1.00e+00 | 3.569 | 2 | 8 | 221 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 16 |
GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0010467 | gene expression | 1.24e-02 | 1.00e+00 | 2.556 | 3 | 45 | 669 |
GO:0090316 | positive regulation of intracellular protein transport | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 2 | 17 |
GO:0003713 | transcription coactivator activity | 1.34e-02 | 1.00e+00 | 3.468 | 2 | 24 | 237 |
GO:0030332 | cyclin binding | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 18 |
GO:0008134 | transcription factor binding | 1.40e-02 | 1.00e+00 | 3.438 | 2 | 18 | 242 |
GO:0014003 | oligodendrocyte development | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 5 | 20 |
GO:0043484 | regulation of RNA splicing | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0006611 | protein export from nucleus | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 3 | 25 |
GO:0016925 | protein sumoylation | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0043392 | negative regulation of DNA binding | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 4 | 26 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:0046966 | thyroid hormone receptor binding | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 6 | 26 |
GO:0015631 | tubulin binding | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 2 | 27 |
GO:0034605 | cellular response to heat | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 28 |
GO:0072686 | mitotic spindle | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 29 |
GO:0006606 | protein import into nucleus | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 2 | 30 |
GO:0031647 | regulation of protein stability | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 4 | 30 |
GO:0010827 | regulation of glucose transport | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 4 | 30 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 3 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 32 |
GO:0003682 | chromatin binding | 2.46e-02 | 1.00e+00 | 3.004 | 2 | 19 | 327 |
GO:0031072 | heat shock protein binding | 2.49e-02 | 1.00e+00 | 5.312 | 1 | 2 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 2.49e-02 | 1.00e+00 | 5.312 | 1 | 8 | 33 |
GO:0016592 | mediator complex | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 10 | 35 |
GO:0030178 | negative regulation of Wnt signaling pathway | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 4 | 35 |
GO:0003723 | RNA binding | 2.68e-02 | 1.00e+00 | 2.939 | 2 | 18 | 342 |
GO:0007077 | mitotic nuclear envelope disassembly | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 4 | 36 |
GO:0032880 | regulation of protein localization | 2.79e-02 | 1.00e+00 | 5.147 | 1 | 2 | 37 |
GO:0008645 | hexose transport | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 4 | 39 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0030521 | androgen receptor signaling pathway | 3.08e-02 | 1.00e+00 | 4.999 | 1 | 5 | 41 |
GO:0019898 | extrinsic component of membrane | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 42 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 3.23e-02 | 1.00e+00 | 4.930 | 1 | 7 | 43 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.31e-02 | 1.00e+00 | 4.897 | 1 | 3 | 44 |
GO:0003712 | transcription cofactor activity | 3.31e-02 | 1.00e+00 | 4.897 | 1 | 8 | 44 |
GO:0019827 | stem cell maintenance | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 7 | 47 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.79e-02 | 1.00e+00 | 2.667 | 2 | 24 | 413 |
GO:0000910 | cytokinesis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0000226 | microtubule cytoskeleton organization | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 2 | 52 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.97e-02 | 1.00e+00 | 4.629 | 1 | 5 | 53 |
GO:0015758 | glucose transport | 4.12e-02 | 1.00e+00 | 4.575 | 1 | 4 | 55 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 9 | 60 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 3 | 62 |
GO:0000776 | kinetochore | 4.70e-02 | 1.00e+00 | 4.379 | 1 | 5 | 63 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0060021 | palate development | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 1 | 72 |
GO:0003729 | mRNA binding | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 4 | 72 |
GO:0001843 | neural tube closure | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 4 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0009653 | anatomical structure morphogenesis | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 2 | 83 |
GO:0016605 | PML body | 6.51e-02 | 1.00e+00 | 3.897 | 1 | 3 | 88 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.77e-02 | 1.00e+00 | 2.202 | 2 | 37 | 570 |
GO:0001649 | osteoblast differentiation | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 5 | 92 |
GO:0046872 | metal ion binding | 7.06e-02 | 1.00e+00 | 1.590 | 3 | 29 | 1307 |
GO:0042803 | protein homodimerization activity | 7.30e-02 | 1.00e+00 | 2.140 | 2 | 19 | 595 |
GO:0003676 | nucleic acid binding | 7.87e-02 | 1.00e+00 | 3.615 | 1 | 2 | 107 |
GO:0030529 | ribonucleoprotein complex | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 5 | 112 |
GO:0005635 | nuclear envelope | 8.29e-02 | 1.00e+00 | 3.536 | 1 | 5 | 113 |
GO:0005215 | transporter activity | 9.48e-02 | 1.00e+00 | 3.334 | 1 | 3 | 130 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9.66e-02 | 1.00e+00 | 1.908 | 2 | 39 | 699 |
GO:0045202 | synapse | 9.90e-02 | 1.00e+00 | 3.269 | 1 | 5 | 136 |
GO:0007507 | heart development | 1.01e-01 | 1.00e+00 | 3.238 | 1 | 7 | 139 |
GO:0006974 | cellular response to DNA damage stimulus | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 7 | 151 |
GO:0046777 | protein autophosphorylation | 1.14e-01 | 1.00e+00 | 3.053 | 1 | 4 | 158 |
GO:0008022 | protein C-terminus binding | 1.16e-01 | 1.00e+00 | 3.026 | 1 | 8 | 161 |
GO:0043687 | post-translational protein modification | 1.17e-01 | 1.00e+00 | 3.017 | 1 | 5 | 162 |
GO:0000398 | mRNA splicing, via spliceosome | 1.18e-01 | 1.00e+00 | 2.999 | 1 | 15 | 164 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.19e-01 | 1.00e+00 | 1.733 | 2 | 41 | 789 |
GO:0005667 | transcription factor complex | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 17 | 175 |
GO:0004672 | protein kinase activity | 1.27e-01 | 1.00e+00 | 2.889 | 1 | 3 | 177 |
GO:0015629 | actin cytoskeleton | 1.27e-01 | 1.00e+00 | 2.889 | 1 | 5 | 177 |
GO:0003714 | transcription corepressor activity | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 11 | 178 |
GO:0019904 | protein domain specific binding | 1.28e-01 | 1.00e+00 | 2.873 | 1 | 8 | 179 |
GO:0005737 | cytoplasm | 1.33e-01 | 1.00e+00 | 0.799 | 5 | 124 | 3767 |
GO:0004872 | receptor activity | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 8 | 189 |
GO:0007067 | mitotic nuclear division | 1.60e-01 | 1.00e+00 | 2.530 | 1 | 6 | 227 |
GO:0030425 | dendrite | 1.62e-01 | 1.00e+00 | 2.511 | 1 | 6 | 230 |
GO:0006355 | regulation of transcription, DNA-templated | 1.74e-01 | 1.00e+00 | 1.395 | 2 | 43 | 997 |
GO:0005975 | carbohydrate metabolic process | 1.77e-01 | 1.00e+00 | 2.374 | 1 | 8 | 253 |
GO:0006281 | DNA repair | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 14 | 261 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.84e-01 | 1.00e+00 | 2.312 | 1 | 23 | 264 |
GO:0008283 | cell proliferation | 2.24e-01 | 1.00e+00 | 1.999 | 1 | 14 | 328 |
GO:0043565 | sequence-specific DNA binding | 2.34e-01 | 1.00e+00 | 1.922 | 1 | 11 | 346 |
GO:0005524 | ATP binding | 2.60e-01 | 1.00e+00 | 1.015 | 2 | 31 | 1298 |
GO:0000278 | mitotic cell cycle | 2.61e-01 | 1.00e+00 | 1.746 | 1 | 15 | 391 |
GO:0009986 | cell surface | 2.67e-01 | 1.00e+00 | 1.706 | 1 | 9 | 402 |
GO:0043066 | negative regulation of apoptotic process | 2.80e-01 | 1.00e+00 | 1.629 | 1 | 16 | 424 |
GO:0055085 | transmembrane transport | 2.86e-01 | 1.00e+00 | 1.592 | 1 | 8 | 435 |
GO:0044267 | cellular protein metabolic process | 3.08e-01 | 1.00e+00 | 1.468 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.10e-01 | 1.00e+00 | 1.456 | 1 | 24 | 478 |
GO:0016032 | viral process | 3.40e-01 | 1.00e+00 | 1.296 | 1 | 26 | 534 |
GO:0016020 | membrane | 3.73e-01 | 1.00e+00 | 0.642 | 2 | 46 | 1681 |
GO:0005829 | cytosol | 5.92e-01 | 1.00e+00 | 0.071 | 2 | 86 | 2496 |
GO:0044281 | small molecule metabolic process | 6.19e-01 | 1.00e+00 | 0.115 | 1 | 20 | 1211 |